BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 21479248)

  • 1. Methylated HBHA produced in M. smegmatis discriminates between active and non-active tuberculosis disease among RD1-responders.
    Delogu G; Chiacchio T; Vanini V; Butera O; Cuzzi G; Bua A; Molicotti P; Zanetti S; Lauria FN; Grisetti S; Magnavita N; Fadda G; Girardi E; Goletti D
    PLoS One; 2011 Mar; 6(3):e18315. PubMed ID: 21479248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of methylated HBHA expressed from Mycobacterium smegmatis in an IFN-γ release assay to aid discrimination between latent infection and active tuberculosis in BCG-vaccinated populations.
    Wen HL; Li CL; Li G; Lu YH; Li HC; Li T; Zhao HM; Wu K; Lowrie DB; Lv JX; Lu SH; Fan XY
    Eur J Clin Microbiol Infect Dis; 2017 Aug; 36(8):1415-1423. PubMed ID: 28429162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response.
    Butera O; Chiacchio T; Carrara S; Casetti R; Vanini V; Meraviglia S; Guggino G; Dieli F; Vecchi M; Lauria FN; Marruchella A; Laurenti P; Singh M; Caccamo N; Girardi E; Goletti D
    BMC Infect Dis; 2009 Nov; 9():182. PubMed ID: 19930588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QuantiFERON-TB Gold Plus combined with HBHA-Induced IFN-γ release assay improves the accuracy of identifying tuberculosis disease status.
    Tang J; Huang Y; Jiang S; Huang F; Ma T; Qi Y; Ma Y
    Tuberculosis (Edinb); 2020 Sep; 124():101966. PubMed ID: 32866942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune characterization of the HBHA-specific response in Mycobacterium tuberculosis-infected patients with or without HIV infection.
    Chiacchio T; Delogu G; Vanini V; Cuzzi G; De Maio F; Pinnetti C; Sampaolesi A; Antinori A; Goletti D
    PLoS One; 2017; 12(8):e0183846. PubMed ID: 28837654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay].
    Harada N
    Kekkaku; 2006 Nov; 81(11):681-6. PubMed ID: 17154047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of phenotype and absolute number of circulating heparin-binding hemagglutinin, ESAT-6 and CFP-10, and purified protein derivative antigen-specific CD4 T cells can discriminate active from latent tuberculosis infection.
    Hutchinson P; Barkham TM; Tang W; Kemeny DM; Chee CB; Wang YT
    Clin Vaccine Immunol; 2015 Feb; 22(2):200-12. PubMed ID: 25520147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-binding-hemagglutinin-induced IFN-gamma release as a diagnostic tool for latent tuberculosis.
    Hougardy JM; Schepers K; Place S; Drowart A; Lechevin V; Verscheure V; Debrie AS; Doherty TM; Van Vooren JP; Locht C; Mascart F
    PLoS One; 2007 Oct; 2(10):e926. PubMed ID: 17912342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Could inducible protein-10 and heparin-binding hemagglutinin improve the detection of Mycobacterium tuberculosis-infected subjects in a country with low incidence of tuberculosis?
    Molicotti P; Bua A; Cubeddu M; Ruggeri M; Mura MS; Pirina P; Zanetti S
    Infect Dis (Lond); 2015 Aug; 47(8):563-7. PubMed ID: 25856090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-binding, hemagglutinin-specific IFN-gamma synthesis at the site of infection during active tuberculosis in humans.
    Place S; Verscheure V; de San N; Hougardy JM; Schepers K; Dirix V; Dediste A; Michel O; Drowart A; Allard SD; Doherty TM; Lecher S; Locht C; Mascart F
    Am J Respir Crit Care Med; 2010 Sep; 182(6):848-54. PubMed ID: 20508213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-Mediated Immune Responses to
    Coppola M; Villar-Hernández R; van Meijgaarden KE; Latorre I; Muriel Moreno B; Garcia-Garcia E; Franken KLMC; Prat C; Stojanovic Z; De Souza Galvão ML; Millet JP; Sabriá J; Sánchez-Montalva A; Noguera-Julian A; Geluk A; Domínguez J; Ottenhoff THM
    Front Immunol; 2020; 11():103. PubMed ID: 32117257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB Plus.
    Petruccioli E; Chiacchio T; Pepponi I; Vanini V; Urso R; Cuzzi G; Barcellini L; Cirillo DM; Palmieri F; Ippolito G; Goletti D
    J Infect; 2016 Dec; 73(6):588-597. PubMed ID: 27717779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early cellular immune response to a new candidate mycobacterial vaccine antigen in childhood tuberculosis.
    Schepers K; Dirix V; Mouchet F; Verscheure V; Lecher S; Locht C; Mascart F
    Vaccine; 2015 Feb; 33(8):1077-83. PubMed ID: 25583385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proportions of interferon-γ-producing ascites lymphocytes in response to mycobacterial antigens: A help for early diagnosis of peritoneal tuberculosis in a low TB incidence country.
    Henrard S; Corbière V; Schandené L; Ducarme M; Van Praet A; Petit E; Singh M; Locht C; Dirix V; Mascart F
    PLoS One; 2019; 14(4):e0214333. PubMed ID: 30946755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Commercially available CD4 + and CD8 + IFN-γ release assays combined with an HBHA-induced IGRA improve the characterization of the tuberculosis spectrum and monitoring of treatment in children.
    Buonsenso D; Delogu G; Del Carmen Pereyra Boza M; De Maio F; Palucci I; Martino L; Pata D; Sanguinetti M; Valentini P; Sali M
    Eur J Pediatr; 2023 May; 182(5):2155-2167. PubMed ID: 36847873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional, Antigen-Specific Stem Cell Memory (T
    Mpande CAM; Dintwe OB; Musvosvi M; Mabwe S; Bilek N; Hatherill M; Nemes E; Scriba TJ;
    Front Immunol; 2018; 9():324. PubMed ID: 29545791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher frequency of T-cell response to M. tuberculosis latency antigen Rv2628 at the site of active tuberculosis disease than in peripheral blood.
    Chiacchio T; Petruccioli E; Vanini V; Butera O; Cuzzi G; Petrone L; Matteucci G; Lauria FN; Franken KL; Girardi E; Ottenhoff TH; Goletti D
    PLoS One; 2011; 6(11):e27539. PubMed ID: 22102905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFN-gamma, but not IP-10, MCP-2 or IL-2 response to RD1 selected peptides associates to active tuberculosis.
    Goletti D; Raja A; Ahamed Kabeer BS; Rodrigues C; Sodha A; Butera O; Carrara S; Vernet G; Longuet C; Ippolito G; Thangaraj S; Leportier M; Girardi E; Lagrange PH
    J Infect; 2010 Jul; 61(2):133-43. PubMed ID: 20470822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculosis patients are characterized by a low-IFN-γ/high-TNF-α response to methylated HBHA produced in M. smegmatis.
    Molicotti P; Bua A; Cubeddu M; Cannas S; Delogu G; Zanetti S
    Diagn Microbiol Infect Dis; 2011 Dec; 71(4):449-52. PubMed ID: 22083081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.